Amarin (AMRN) NCE Exclusivity Doesn't Move Estimates But Should Help Strategic Discussions, Oppenheimer Says
Tweet Send to a Friend
Oppenheimer analyst Akiva Felt weighed in on Amarin Corporation (NASDAQ: AMRN) after the company won a summary judgment ruling (Federal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
